00

Yunnan Baiyao Group Co LtdSHE 000538 Stock Report

Last reporting period 30 Jun, 2024

Updated 18 Sep, 2024

Last price

Market cap $B

12.559

Large

Exchange

XSHE - Shenzhen Stock Exchange

000538.SZ Stock Analysis

00

Uncovered

Yunnan Baiyao Group Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

70/100

Moderate score

Market cap $B

12.559

Dividend yield

6.37 %

Shares outstanding

1 784.26 B

Yunnan Baiyao Group Co., Ltd. engages in the research, development, production and sales of modern medicine. The company is headquartered in Kunming, Yunnan and currently employs 8,464 full-time employees. The Company’s products are categorized into traditional Chinese medicine resources, Chinese and western raw medicine materials and preparations, personal care products and raw materials, with Yunnan Baiyao band-aids, Yunnan Baiyao aerosol and Yunnan Baiyao ointment as its main effective products. The firm also provides skin care products and health care products. The firm distributes its products within domestic market and to overseas markets, with domestic market as its main market.

View Section: Eyestock Rating